119 related articles for article (PubMed ID: 16475692)
1. Limited suitability of EpCAM for molecular staging of tumor borders in head and neck cancer.
Andratschke M; Hagedorn H; Luebbers CW; Schmitt B; Lang S; Zeidler R; Wollenberg B
Anticancer Res; 2006; 26(1A):153-8. PubMed ID: 16475692
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy.
Yanamoto S; Kawasaki G; Yoshitomi I; Iwamoto T; Hirata K; Mizuno A
Oral Oncol; 2007 Oct; 43(9):869-77. PubMed ID: 17207659
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients.
de Carvalho AC; Kowalski LP; Campos AH; Soares FA; Carvalho AL; Vettore AL
Oral Oncol; 2012 Mar; 48(3):240-8. PubMed ID: 22104250
[TBL] [Abstract][Full Text] [Related]
4. Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases.
Cortesina G; Martone T; Galeazzi E; Olivero M; De Stefani A; Bussi M; Valente G; Comoglio PM; Di Renzo MF
Int J Cancer; 2000 May; 89(3):286-92. PubMed ID: 10861506
[TBL] [Abstract][Full Text] [Related]
5. EPCAM-A novel molecular target for the treatment of pediatric and adult germ cell tumors.
Schönberger S; Okpanyi V; Calaminus G; Heikaus S; Leuschner I; Nicholson JC; Stoecklein NH; Schneider DT; Borkhardt A
Genes Chromosomes Cancer; 2013 Jan; 52(1):24-32. PubMed ID: 22987628
[TBL] [Abstract][Full Text] [Related]
6. Ep-CAM--a marker for the detection of disseminated tumor cells in patients suffering from SCCHN.
Chaubal S; Wollenberg B; Kastenbauer E; Zeidler R
Anticancer Res; 1999; 19(3B):2237-42. PubMed ID: 10472336
[TBL] [Abstract][Full Text] [Related]
7. Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma.
Seligson DB; Pantuck AJ; Liu X; Huang Y; Horvath S; Bui MH; Han KR; Correa AJ; Eeva M; Tze S; Belldegrun AS; Figlin RA
Clin Cancer Res; 2004 Apr; 10(8):2659-69. PubMed ID: 15102668
[TBL] [Abstract][Full Text] [Related]
8. Expression of epithelial cell adhesion molecule in gallbladder carcinoma and its correlation with clinicopathologic variables.
Prince S; Zeidman A; Dekel Y; Ram E; Koren R
Am J Clin Pathol; 2008 Mar; 129(3):424-9. PubMed ID: 18285265
[TBL] [Abstract][Full Text] [Related]
9. EpCAM expression in squamous cell carcinoma of the oral cavity: frequency and relationship to clinicopathologic features.
Laimer K; Fong D; Gastl G; Obrist P; Kloss F; Tuli T; Gassner R; Rasse M; Norer B; Spizzo G
Oral Oncol; 2008 Jan; 44(1):72-7. PubMed ID: 17418618
[TBL] [Abstract][Full Text] [Related]
10. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
11. Expression of epithelial cell adhesion molecule (EpCAM) in oral squamous cell carcinoma.
Sen S; Carnelio S
Histopathology; 2016 May; 68(6):897-904. PubMed ID: 26401964
[TBL] [Abstract][Full Text] [Related]
12. EpCAM overexpression in thyroid carcinomas: a histopathological study of 121 cases.
Ensinger C; Kremser R; Prommegger R; Spizzo G; Schmid KW
J Immunother; 2006; 29(5):569-73. PubMed ID: 16971812
[TBL] [Abstract][Full Text] [Related]
13. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.
Menéndez ST; Rodrigo JP; Allonca E; García-Carracedo D; Alvarez-Alija G; Casado-Zapico S; Fresno MF; Rodríguez C; Suárez C; García-Pedrero JM
J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490
[TBL] [Abstract][Full Text] [Related]
14. RhoC GTPase expression as a potential marker of lymph node metastasis in squamous cell carcinomas of the head and neck.
Kleer CG; Teknos TN; Islam M; Marcus B; Lee JS; Pan Q; Merajver SD
Clin Cancer Res; 2006 Aug; 12(15):4485-90. PubMed ID: 16899593
[TBL] [Abstract][Full Text] [Related]
15. Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors.
Rao CG; Chianese D; Doyle GV; Miller MC; Russell T; Sanders RA; Terstappen LW
Int J Oncol; 2005 Jul; 27(1):49-57. PubMed ID: 15942643
[TBL] [Abstract][Full Text] [Related]
16. Expression of the Epithelial Cell Adhesion Molecule and Cytokeratin 8 in Head and Neck Squamous Cell Cancer: A Comparative Study.
Andratschke M; Hagedorn H; Nerlich A
Anticancer Res; 2015 Jul; 35(7):3953-60. PubMed ID: 26124342
[TBL] [Abstract][Full Text] [Related]
17. Tumor-specific glycosylation of the carcinoma-associated epithelial cell adhesion molecule EpCAM in head and neck carcinomas.
Pauli C; Münz M; Kieu C; Mack B; Breinl P; Wollenberg B; Lang S; Zeidler R; Gires O
Cancer Lett; 2003 Apr; 193(1):25-32. PubMed ID: 12691820
[TBL] [Abstract][Full Text] [Related]
18. Significance of EpCAM and TROP2 expression in non-small cell lung cancer.
Pak MG; Shin DH; Lee CH; Lee MK
World J Surg Oncol; 2012 Apr; 10():53. PubMed ID: 22482828
[TBL] [Abstract][Full Text] [Related]
19. The involvement of promoter methylation and DNA methyltransferase-1 in the regulation of EpCAM expression in oral squamous cell carcinoma.
Shiah SG; Chang LC; Tai KY; Lee GH; Wu CW; Shieh YS
Oral Oncol; 2009 Jan; 45(1):e1-8. PubMed ID: 18485790
[TBL] [Abstract][Full Text] [Related]
20. Correlation of tumor marker expression with nodal disease burden in metastatic head and neck cancer.
Trivedi S; Mattos J; Gooding W; Godfrey TE; Ferris RL
Otolaryngol Head Neck Surg; 2013 Aug; 149(2):261-8. PubMed ID: 23625795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]